C1 Esterase Inhibitor Deficiency
5 clinical trials · Condition
◉ Watch C1 Esterase Inhibitor Deficiency
| Record | Firm | Date |
|---|---|---|
| Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (NCT05047185) | Pharvaris Netherlands B.V. | 2022-04-19 |
| Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (NCT04618211) | Pharvaris Netherlands B.V. | 2021-02-03 |
| Biomarker for Hereditary AngioEdema Disease (NCT03029728) | CENTOGENE GmbH Rostock | 2018-08-20 |
Track C1 Esterase Inhibitor Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.